WebHerceptin Clinical Trials. A listing of Herceptin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area. WebPertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PhesgoTM) MA08.129: 11/30/2024: 11/30/2024: This is a New Policy. Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf …
Monica Hagan Vetter, MD - Gynecologic Oncology - Baptist Health
WebThis phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. WebIn late June, our partner Roche received FDA approval for Phesgo™, a fixed-dose combination of two monoclonal antibodies, Perjeta® and Herceptin®, utilizing our ENHANZE® technology for the treatment of patients with HER2-positive breast cancer. blessings timeline facebook covers
Uterine Corpus Carcinosarcoma clinical trials at UC Cancer
WebSigma-Aldrich - P5566 Page 2 of 12 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada WebThis phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. WebThis phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. freddy nolasco